Ekkehart Lausch

Current Position

Attending Physician

Academic Education

1984 - 1993	M.D., Johannes Gutenberg University, Mainz
1984 - 1989	Diploma in Chemistry, Johannes Gutenberg University, Mainz

Advanced Qualifications

2013	Habilitation, University of Freiburg
2009	Board Certification, Human Genetics
2004	Board Certification, Pediatrics
1997	Fellow in Emergency Medicine, Rush Medical College, Chicago, Illinois, USA
1996	M.D., PhD (Molecular Oncology), University of Illinois, Department of Genetics, College of Medicine, Illinois, USA

Postgraduate Positions

2013 - present	Head, Section of Pediatric Genetics, Medical Center - University of Freiburg
2008 - present	Attending Physician, Department of Pediatrics, Medical Center - University of Freiburg
2004 - 2007	Clinical Fellow (Pediatrics) & Resident in Clinical Genetics, Johannes Gutenberg University, Mainz
1999 - 2004	Resident in Pediatrics, Johannes Gutenberg University, Mainz
1997 - 1998	Research Assistant Professor, Department of Genetics, College of Medicine, University of Illinois, Chicago, Illinois, USA
1996 - 1997	Postdoctoral Research Fellow, University of Illinois, Department of Genetics, College of Medicine, Chicago, Illinois, USA
1994 - 1996	Resident in Emergency Medicine, University of Illinois and Rush University, Chicago, Illinois, USA

Link to all publications of Ekkehart Lausch: PubMed

Publications on CRC 1453 funding

Getwan M, Hoppmann A, Schlosser P, Grand K, Song W,…, Lausch E, Köttgen A, Lienkamp SS. Ttc30a affects tubulin modifications in a model for ciliary chondrodysplasia with polycystic kidney disease. Proc Natl Acad Sci USA (2021). Schüle I, Berger U, Matysiak U, Ruzaike G, Stiller B, …, Lausch E, Grünert SC, Schmidts M. A Homozygous Deletion of Exon 5 of KYNU Resulting from a Maternal Chromosome 2 Isodisomy (UPD2) Causes Catel-Manzke-Syndrome/VCRL Syndrome. Genes (2021). Grünert SC, Matysiak U, Hodde F, Ruzaike G, Lausch E, Schumann A, van der Werf-Grohmann N, Spiekerkoetter U, Schmidts M. Isolated Hypomethylation of IGF2 Associated with Severe Hypoglycemia Responsive to Growth Hormone Treatment. Diagnostics (Basel) (2021).